Trial
NCT02705378
The Effect of Naloxegol on Refractory Constipation in the Intensive Care Unit
Phase IIIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Massachusetts General Hospital
Collaborators
AstraZeneca
Condition
Constipation
Intervention
Polyethylene glycol
Why stopped
PI left institution. Protocol never submitted to the IRB, no contract executed only Confidentiality Agreement, and study not done.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-05-05